Literature DB >> 24638151

Alterations of costimulatory molecules and instructive cytokines expressed by dendritic cells in the microenvironment of an endogenous mouse lymphoma.

Marcella Naujoks1, Jakob Weiß, Tanja Riedel, Nadine Hömberg, Margarethe Przewoznik, Elfriede Noessner, Martin Röcken, Ralph Mocikat.   

Abstract

Costimulatory surface molecules and instructive cytokines expressed by dendritic cells (DCs) determine the outcome of an immune response. In malignant disease, DCs are often functionally compromised. In most tumors studied so far, the deficient induction of effective T cell responses has been associated with a blockade of DC maturation, but little has been known on DCs infiltrating malignant B cell lymphoma. Here, we investigated for the first time the phenotypic and functional status of DCs in B cell lymphoma, and we analyzed the network of DCs, tumor cells, natural killer (NK) cells and cytokines present in the tumor micromilieu. Therefor, we used an endogenous myc-transgenic mouse lymphoma model, because transplanted tumor cells foster an IFN-γ-driven Th1 antitumor response rather than an immunosuppressive environment, which is observed in autochthonous neoplasias. Lymphoma-infiltrating DCs showed a mature phenotype and a Th2-inducing cytokine pattern. This situation is in contrast to most human malignancies and mouse models described. Cellular contacts between DCs and tumor cells, which involved CD62L on the lymphoma, caused upregulation of costimulatory molecules, whereas IL-10 primarily derived from lymphoma cells induced an IL-12/IL-10 shift in DCs. Thus, alteration of costimulatory molecules and instructive cytokines was mediated by distinct mechanisms. Normal NK cells were able to additionally modulate DC maturation but this effect was absent in the lymphoma environment where IFN-γ production by NK cells was severely impaired. These data are relevant for establishing novel immunotherapeutic approaches against B cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24638151     DOI: 10.1007/s00262-014-1538-7

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  2 in total

1.  Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours.

Authors:  Ellen Brenner; Barbara F Schörg; Fatima Ahmetlić; Thomas Wieder; Franz Joachim Hilke; Nadine Simon; Christopher Schroeder; German Demidov; Tanja Riedel; Birgit Fehrenbacher; Martin Schaller; Andrea Forschner; Thomas Eigentler; Heike Niessner; Tobias Sinnberg; Katharina S Böhm; Nadine Hömberg; Heidi Braumüller; Daniel Dauch; Stefan Zwirner; Lars Zender; Dominik Sonanini; Albert Geishauser; Jürgen Bauer; Martin Eichner; Katja J Jarick; Andreas Beilhack; Saskia Biskup; Dennis Döcker; Dirk Schadendorf; Leticia Quintanilla-Martinez; Bernd J Pichler; Manfred Kneilling; Ralph Mocikat; Martin Röcken
Journal:  Nat Commun       Date:  2020-03-12       Impact factor: 14.919

2.  Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescence.

Authors:  Martin Röcken; Ralph Mocikat; Fatima Ahmetlic; Josia Fauser; Tanja Riedel; Vera Bauer; Carolin Flessner; Nadine Hömberg; Roman Hennel; Ellen Brenner; Kirsten Lauber
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 13.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.